World Blood Glucose Monitoring (BGM) Devices Market Report, 2017-2026, Featuring Profiles of 48 Major Companies

Dublin, Feb. 06, 2020 (GLOBE NEWSWIRE) — The “Blood Glucose Monitoring (BGM) Devices – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering.The market for Blood Glucose Monitoring Devices is driven by rising prevalence of diabetes worldwide and increasing geriatric population. Additionally, growing awareness about diabetes preventive care and new technology developments are expected to boost the market. Blood glucose monitoring devices are used to measure blood glucose levels in diabetic patients.Global market for Blood Glucose Monitoring Devices is studied in this report with respect to product categories, product types and end-use sectorsThe report estimates/projects the market size of Blood Monitoring Devices by product categories/types and end-use sectors in each major region/country globally for the analysis periodClosed Loop Artificial Pancreas Effectively Controls Blood Glucose Levels than Conventional TreatmentsFlash Glucose Monitoring Improves Glucose Control at High Risk of DysglycemiaSalivary Proteome Test May Predict and Prevent Type 1 Diabetes ComplicationsArtificial Intelligence (AI)and Radar Technologies to Monitor Blood Glucose LevelsKey business trends focusing on product innovations/developments, M&As, JVs and other recent industry developmentsMajor companies profiled – 48The industry guide includes the contact details for 206 companies
The market for product categories/types of Blood Glucose Monitoring Devices is analyzed in this study includes the following:Monitoring Blood Glucose (SMBG) DevicesGlucometer DevicesTest StripsLancetsContinuous Blood Glucose Monitoring (CBGM) DevicesSensorsTransmitters & ReceiversInsulin PumpsThe report analyzes the market for the major end-use sectors of Blood Glucose Monitoring Devices including:Hospitals and ClinicsHome SettingsDiagnostic Centers
Geographic CoverageNorth America (The United States, Canada and Mexico)Europe (Germany, France, the United Kingdom, Italy, Spain and Rest of Europe)Asia-Pacific (Japan, China, India, South Korea and Rest of Asia-Pacific)South America (Brazil, Argentina and Rest of South America)Rest of WorldKey Topics Covered
PART A: GLOBAL MARKET PERSPECTIVEAbbott Laboratories (United States)Apex Biotechnology Corp. (Taiwan)Ascensia Diabetes Care Holdings AG (Switzerland)B. Braun Melsungen AG (Germany)Becton, Dickinson and Company (United States)Beurer GmbH (Germany)Bionime Corporation (Taiwan)Cequr S.A. (Switzerland)Cnoga Medical Ltd. (Israel)Dariohealth Corp. (United States)Entra Health Systems LLC (United States)F. Hoffmann-La Roche AG (Switzerland)Insulet Corporation (United States)Lifescan, Inc. (United States)Medtronic PLC (Ireland)Medtronic Diabetes (United States)Nipro Corporation (Japan)Nipro Diagnostics (Uk) LimitedNipro Australia Pty Ltd.Nova Biomedical (United States)Novo Nordisk A/S (Denmark)Omron Healthcare Co. Ltd. (Japan)Rossmax International Ltd. (Taiwan)Sanofi S.A. (France)Sanwa Kagaku Kenkyusho Co. Ltd. (Japan)Senseonics Holdings, Inc. (United States)Sinocare Inc. (China)Taidoc Technology Corporation (Taiwan)Terumo Corporation (Japan)Trividia Health, Inc. (United States)4. KEY BUSINESS & PRODUCT TRENDSLaunch of Omnipod DASH System in the United Kingdom and the Netherlands by InsuletKlue Acquired by MedtronicUS FDA Granted Breakthrough Device Designation for Beta Bionics’ iLet Bionic Pancreas SystemLaunch of BEAT Diabetes Offering Broadened Nemaura’s SugarBEAT CGM CapabilitiesLaunch of DarioHealth’s Digital Diabetes Program on Walmart.comNew Eversense CGM System with Non-Adjunctive Claim Introduced by Senseonics in United StatesTandem Diabetes Care’s t:slim X2 Insulin Pump with Basal-IQ Technology Approved by Health CanadaUnveiling of ACON Laboratories’ On Call Extra Mobile Glucose Monitoring Systems in Europe and Latin AmericaUS FDA Clearance for Use of Novo Nordisk’s Fiasp Insulin with Insulet’s Omnipod Systems for AdultsYpsomed Broadened Diabetes Therapy Offerings by Forming New CollaborationsAbbott Joined Forces with Tandem Diabetes Care to Develop and Commercialize Integrated Diabetes SolutionsAbbott in Collaboration with Omada Health Develop Integrated Digital Health and Coaching Solution for Type 2 DiabeticsPartnership of LifeScan and Willis Towers Watson Broaden the Adoption of OneTouch Reveal PlusInsulet Receives FDA Clearance to Market Omnipod DASH System as an Integrated Insulin PumpAbbott Develops New Tools and Connectivity with Sanofi to Drive Meaningful Change in Diabetes CareLaunch of On Call Express Voice by ACON Laboratories in the USMedtronic and Novo Nordisk Form Digital Solutions Development Pact to Aid DiabeticsPublic Reimbursement for Abbott’s FreeStyle Libre System in Ontario and QuebecOpening Ceremony of Ypsomed’s Schwerin Production UnitMarket Launch of Insulet Omnipod DASH System Mobile AppsFirst Shipments of Nemaura Medical’s SugarBEAT CGM to Diabetics and Pre-Diabetics in the UKBeta Bionics Forms Infusion Set Development Pact with ConvaTec’s Unomedical SubsidiaryApplication for De Novo 510(k) Clearance from US FDA Submitted by Nemaura Medical for SugarBEATFDA Approves Senseonics’ Eversense 90-Day CGM System with Non-Adjunctive ClaimNemaura Medical’s SugarBEAT CGM Receives CE Mark ApprovalLifeScan and Sanvita Medical Form CGM Sensors Distribution PactInauguration of Insulet’s New Global Headquarters and Production Plant in USNemaura’s SugarBEAT Integrated with New Predictive Alert FunctionalityLifeScan’s New OneTouch Verio Reflect System Receives Health Canada ApprovalLifeScan Launches OneTouch Reveal Plus Mobile App in CanadaUpgrading and Expansion of Novo Nordisk’s Manufacturing Plants in DenmarkProduction and Commercial Operations of Cellnovo DiscontinuedEversense Bridge Patient Access Program Launched by Senseonics in the USKeto-Mojo Form Personal Health Management Solution Development Pact with Heads Up HealthTPMENA to Distribute Nemaura Medical’s SugarBEAT CGM in the Gulf Cooperation Council RegionTandem Diabetes Care is Now an Approved Vendor of Insulin Pumps for ADP in OntarioIntegration of Eversense CGM Data into Glooko Diabetes Data Management PlatformTerumo to Sell Dexcom G4 Platinum CGM System in JapanBIOCORP Partnered with DreaMed Diabetes Concerning a Global Solution for Diabetes ComplianceAbbott Inked a Non-Exclusive Partnership with Novo Nordisk to Make Diabetes Management EasierUS FDA Classified t:slim X2 Insulin Pump as the First in New ACE Pump CategorySenseonics and Geo-Med Join Forces for Providing Access to Eversense CGM to Diabetic VeteransUS Patent Granted for Nemaura Medical’s SugarBEAT Glucose Sensing AlgorithmFDA Indication for MRI Received by Eversense CGM SensorBD Nano 2nd Generation Pen Needles Receives US FDA 510(k) ClearanceAscensia and POCTech to Co-Develop Next Generation CGM SystemsNemaura to Commercially Launch SugarBEAT in QatarDevelopment of Samsung Galaxy Smartphone-Controlled Omnipod SystemLifeScan Diabetes Institute is the New Name of Johnson & Johnson Diabetes InstituteEversense CGM Receives FDA Approval to Train and Certify Healthcare Providers on Sensor PlacementOneTouch Verio Reflect Blood Glucose Meter Revealed by LifeScanLifeScan Unveils Latest Version of OneTouch Reveal Mobile AppInnovus Pharma’s GlucoGorx Blood Glucose Monitoring System and Test Strip Eligible for Medicare ReimbursementHealth Canada Medical Device License Granted for Tandem Diabetes Care’s t:slim X2 Insulin PumpNovo Nordisk’s Fiasp Safe for Use in Insulet’s Omnipod Insulin Management System in EuropeCE Mark for Abbott’s FreeStyle Libre 2 System in EuropePlans to Launch Novo Nordisk’s First Connected Insulin PensARKRAY and A&T Corporation Form Business Development Pact in Diabetes TestingNew Patent from US PTO Broadens GlySens Incorporated’s Glucose Sensor Patent PortfolioYpsomed to Develop mylife YpsoPump Insulin Pump in Collaboration with JDRFt:slim X2 Insulin Pump with Basal-IQ Technology Unveiled by Tandem Diabetes Care in the USZiylo Ltd Fully Acquired by Novo NordiskCuraTec Nordic’s Initial Order for 100 Units of GlucoTrackEversense CGM System Now Accessible at Trained and Authorized US Diabetes ClinicsUS FDA Approves Abbott’s FreeStyle Libre 14 Day Flash Glucose Monitoring systemIntegrity Applications and CuraTec Nordic Form GlucoTrack Distribution PactCeQur to Launch Two New Wearable Insulin PensFDA Granted 510(k) Clearance to StatStrip Glucose Hospital Meter SystemCalibra Acquired by CeQurBeta Bionics Receives FDA Approval to Begin Home-Use Clinical Testing of an Eversense-integrated iLet Bionic Pancreas SystemInsulet and Glooko Join Forces to Remotely Sync Omnipod System Data Using Glooko+diasendIntegration of Senseonics’ Eversense CGM Systems with Glooko’s Diabetes Data Management PlatformMediWise Acquired by MTIInsulet’s Omnipod System Selected as the Preferred Insulin Pump for Diabetics in British ColumbiaDirect Commercial Operations of Insulet’s Omnipod System Started in EuropeCE Mark Approval for Medtronic’s MiniMed 670G Hybrid Closed Loop SystemCommercial Accessibility of Sugar.IQ Smart Diabetes AssistantFDA Approval for Medtronic’s MiniMed 670G Hybrid Closed Loop System for T1D Children aged 7-13Senseonics’ Eversense CGM System Receives Premarket Approval from FDATandem’s t:slim X2 Insulin Pump with Basal-IQ Technology Receives FDA ApprovalUS FDA Granted a De Novo Request for DreaMed Advisor ProDexcom G5, the First and Only Mobile-Enabled CGM System for Medicare Diabetes PatientsIntegration of Senseonics’ Eversense CGM System into Beta Bionics’ iLet Bionic Pancreas SystemFDA 510 (k) Clearance for Insulet’s Omnipod DASH Insulin Management SystemNemaura Medical and Dallas Burston Ethitronix Collaborated for European Commercialization of SugarBEATBeta Bionics Obtains FDA Approval to Start a Home-Use Clinical Trial of iLet Bionic PancreasAscensia Diabetes Care Launches Upgraded CONTOURDIABETES Application to Support Self-ManagementTerumo to be the Exclusive Distributor of Dexcom’s Continuous Glucose Monitoring Systems in JapanInsulet to Partner with Two Highly-Experienced Diabetes Distributors to Expand into EuropeTandem’s t: slim X2 Insulin Pump Gains CE MarkTandem Diabetes Care Inks Insulin Pump Distribution Deals in Australia and New ZealandTandem Diabetes Care to Enter Distribution Deal with Movi SpABionime to Open Subsidiary in MalaysiaYpsomed to Establish its First Subsidiary in North AmericaMarket Approval for New DexCom G6 Continuous Glucose Monitoring System from FDAFDA Approves Medtronic’s Guardian Connect Continuous Glucose Monitoring SystemFor SugarBEAT Commercial Launch, Nemaura Expands Manufacturing CapabilitiesMedtronic Wins FDA Approval for New Guardian Sensor 3 Arm IndicationMedtronic Launches MiniMed Mio Advance Infusion SetSenseonics Holdings to Unveil Updated Eversense Continuous Glucose Monitoring System in EMEA MarketsTandem Diabetes Care, Rubin Medical Signs Distribution Deal for Insulin Pump ProductsDreaMed Diabetes’ Insulin Therapy Management Platform Wins CE MarkAbbott Launches Freestyle LibreLink Glucose Monitoring Mobile Application in EuropeYpsomed Introduces Mylife App for Digital Diabetes Therapy SolutionsARKRAY Strengthens Production Capacity in ChinaAscensia Diabetes Care, Insulet Corporation to Enter into Non-Exclusive Commercial DealIntuity Medical Receives $70M Debt and Equity Fund to Launch POGO Automatic Blood Glucose Monitoring SystemAbbott’s FreeStyle Libre CGM System Available to Medicare PatientsTandem Inaugurates New Manufacturing Facility in San DiegoIntegrity Applications, MediReva to Enter into Distribution Agreement for GlucoTrack in the NetherlandsZealand Pharma and Beta Bionics Reinforces Their Partnership to Advance the Development of a Dual- Hormone Bionic PancreasTandem Diabetes Care Issued U.S. Patent: Insulin Pump Based Expert SystemAscensia Diabetes Care to Partner with Health2sync to Bring Digital Diabetes SolutionYpsomed to Supply Bigfoot Biomedical with Orbit Infusion SetsYpsomed to Establish New Subsidiaries in EuropeFDA Approved Abbott’s Freestyle Libre Flash Glucose Monitoring SystemARKRAY Expands the Line-Up for the BG SensorBD Launches Ultra-Fine Micro 6mm Pen Needles for Injection PensNHS Reimbursement Approval for Abbott’s Freestyle Libre SystemAscensia Diabetes Care Inks Technology Collaboration Quattro FoliaEversense XL Continuous Glucose Monitoring System Receives CE Mark ApprovalNew Stat Profile Prime plus VET Critical Care Analyzer from Nova BiomedicalAbbott’s Freestyle Libre System Gains Reimbursement in JapanNemaura and Device Technologies to Sign Heads of Agreement for SugarBEATSenseonics to Collaborate With TypeZero Technologies and Roche Diabetes CareBionime Corporation Unveils GM700SB Bluetooth Glucometer in TaiwanAbbott and Bigfoot Biomedical to Partner to Develop Diabetes TechnologiesHealth Canada License Approval for Abbott’s Freestyle Libre Flash Glucose Monitoring SystemAscensia Diabetes Care Enters Global Technology Partnership with VoluntisAscensia Diabetes Care Inks Strategic Alliance Deal with Insulet CorporationMedtronic’s MiniMed 670 G Hybrid Closed Loop System in the US Launched by AscensiaDexcom G5 Mobile App for Android Devices Wins US FDA ApprovalSenseonics Holdings and TypeZero Technologies Inks R&D License DealFrench Health Ministry Grants National Reimbursement for Abbott’s Freestyle Libre SystemBiocon Launches Ypsomed’s INSUPen Pro Introduced in MalaysiaCE Mark Approval for Nova Biomedical’s Allegro AnalyzerAscensia and Glooko Collaborate to Integrate Diabetes Management SolutionsTerumo to Open a New Branch in YangonDexCom Introduces Cloud-Based Diabetes Platform in EMEADexCom Launches G5 Mobile CGM System in Europe and South Africa5. GLOBAL MARKET OVERVIEW
5.1 Global Blood Glucose Monitoring Devices Market Overview by Product Category
5.1.1 Global Self-Monitoring Blood Glucose Devices Market Overview by Geographic Region
5.1.2 Global Self-Monitoring Blood Glucose Devices Market by Product Type
5.1.2.1 Self-Monitoring Blood Glucose Devices Product Type Market Overview by Global Region
5.1.2.1.1 SMBG Glucometer Devices
5.1.2.1.2 SMBG Test Strips
5.1.2.1.3 SMBG Lancets
5.1.3 Global Continuous Blood Glucose Monitoring Devices Market Overview by Geographic Region
5.1.4 Global Continuous Blood Glucose Monitoring Devices Market by Product Type
5.1.4.1 Continuous Blood Glucose Monitoring Devices Product Type Market Overview by Global Region
5.1.4.1.1 CBGM Sensors
5.1.4.1.2 CBGM Transmitters & Receivers
5.1.4.1.3 CBGM Insulin Pumps
5.2 Global Blood Glucose Monitoring Devices Market Overview by End-Use Sector
5.2.1 Global Blood Glucose Monitoring Devices End-Use Sector Market Overview by Global Region
5.2.1.1 Hospitals & Clinics
5.2.1.2 Home Settings
5.2.1.3 Diagnostic Centers6. NORTH AMERICAPART C: GUIDE TO THE INDUSTRY
1. North America
2. Europe
3. Asia-Pacific
4. Rest of World
A-Z List of Companies Mentioned
Abbott LaboratoriesACON Laboratories, Inc.Agamatrix, Inc.Apex Biotechnology Corp.Arkray Inc.Ascensia Diabetes Care Holdings AGB. Braun Melsungen AGBecton, Dickinson and CompanyBeta Bionics, Inc.Beurer GmbHBionime CorporationCequr S.A.Cnoga Medical Ltd.Dariohealth Corp.Debiotech S.A.Dexcom, Inc.Dreamed Diabetes Ltd.Entra Health Systems LLCF. Hoffmann-La Roche AGGlooko Inc.Glucovation, Inc.Glysens IncorporatedInsulet CorporationIntegrity ApplicationsIntuity Medical, Inc.Lifescan, Inc.Medisana GmbHMediwise | Medical Wireless Sensing Ltd.Medtronic PLCNemaura Medical Inc.Nipro CorporationNova BiomedicalNoviosense BVNovo Nordisk A/SOmron Healthcare Co. Ltd.Pharmatech Solutions, Inc.Rossmax International LtdSanofi S.A.Sanwa Kagaku Kenkyusho Co. Ltd.Senseonics Holdings, Inc.Sinocare Inc.Taidoc Technology CorporationTandem Diabetes Care, Inc.Terumo CorporationTrividia Health, Inc.Valeritas, Inc.Ypsomed Holding AGFor more information about this report visit https://www.researchandmarkets.com/r/ss65cxResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900